Dr. Nancy P. Mendenhall, MD

Dr. Mendenhall practices at Florida Proton Therapy Institute Inc in Jacksonville, Florida.

Dr. Mendenhall's NPI, 1407817927, was assigned on April 1, 2006. Dr. Mendenhall graduated from University Of Florida College Of Medicine in 1980. Dr. Mendenhall holds Florida license ME39054.

Dr. Mendenhall's primary practice is Florida Proton Therapy Institute Inc, at 2015 Jefferson N St, Jacksonville, FL 32209 in Duval County. The practice phone is (904) 588-1263.

Dr. Mendenhall's primary practice is Florida Proton Therapy Institute Inc in Jacksonville, Florida. Dr. Mendenhall is also affiliated with UF Health Jacksonville. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Mendenhall to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mendenhall practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Mendenhall's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mendenhall is board certified in therapeutic radiology by the American Board of Radiology. Dmand AI has Dr. Mendenhall's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists breast cancer radiation and prostate cancer radiation among the conditions Dr. Mendenhall treats.

CMS data shows 1,192 Medicare services from Dr. Mendenhall across 17 procedure codes in 2024, for 260 Medicare patients. Medicare paid $432,471 for them. Every service was in an office.

CMS counts 260 Medicare patients who saw Dr. Mendenhall in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mendenhall's median patient age at 67, with 38% women.

In 2024, Dr. Mendenhall wrote 72 Medicare Part D claims for 26 patients. 83% of them were for generic drugs. CMS names the drug for 47 of them, across 1 drug with 11 or more claims each, at $1,221 in total drug cost. In 2023, CMS named 57 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mendenhall for performance year 2024, reported individually. Dr. Mendenhall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mendenhall as offering telehealth.

Dmand AI links 230 papers to Dr. Mendenhall, published from 2005 to 2025. 2019 was the busiest year, with 17. The most frequent topics are Proton Therapy, Radiotherapy Dosage and Prostatic Neoplasms. Dr. Mendenhall has published most often in Int J Radiat Oncol Biol Phys. Dr. Mendenhall's most frequent co-authors are Bradford Scott Hoppe, MD, MPH, William M. Mendenhall, MD and Romaine Charles Nichols, MD.

Dmand AI links Dr. Mendenhall to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. University of Florida sponsors the most, 2.

CMS Open Payments shows 11 general payments to Dr. Mendenhall from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Ion Beam Applications S.A. paid the most, $1,924.

Dmand AI lists 5 awards for Dr. Mendenhall, most recently America's Top Doctors in 2014. Dr. Mendenhall serves on Committee on Appropriateness Criteria Expert Panel on Radiation Oncology - Lymphoma American College of Radiology.

Dr. Mendenhall graduated from University Of Florida College Of Medicine in 1980.

Dr. Mendenhall is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.